NEW DELHI : Apollo Hospitals has partnered with RMS Regrow, the first Make in India company in Cell therapy technology, to offer two new Regenerative Medicine Cell Therapy Products- Ossron and Chondron for bone and cartilage problems, respectively.
The two products Ossron and Chondron, would address unmet clinical needs in the orthopaedic market with respect to sports injuries, accidents and alternate to hip replacement and knee replacement for a young arthritic knee.
Speaking on the occasion, Yash Sanghavi, Founder and CEO of RMS Regrow, said that, we are delighted to partner with a leader like Apollo Hospitals which offers RMS Regrow unprecedented opportunity to reach patients pan India. It has taken 8 years of dedicated effort and innovative research to develop the two revolutionary products that will change the modalities for bone and cartilage treatment in India.
In India, more than 15 lac orthopaedic procedures are performed each year and Regenerative Medicine Cell Therapy is a revolutionary treatment methodology which has immense potential to liberate consumers from joint pain, he added.